BCIS Audit Returns Adult Interventional Procedures
|
|
- Sheila Wright
- 5 years ago
- Views:
Transcription
1 BCIS Audit Returns Adult Interventional Procedures Jan 2009 to Dec 2009 Peter F Ludman BCIS National Audit Lead On behalf of British Cardiovascular Intervention Society Cardiff October 2010
2 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
3 Structure
4 Angiography Centres 2009 New Centres North Tyneside Centres ceasing activity Queen Mary s Sidcup Cambrideg Lea (Spire) Queen s Medical Centre
5 PCI Centres 2009 New PCI Centres Watford General PCI centres from existing angiography units Glan Clwyd (Rhyll) Northampton General Ealing
6 PCI Centres 2009 PCI Centres stopped Hemel Hempstead (moved to Watford) Hull (moved to Castle Hill) Glasgow Royal Informary Glasgow Western Infirmary
7 UK Centres 2009 PCI Angio only No. of Centres
8 2009 Angiography (76) PCI (105)
9 PCI Centres in 2009 UK Countries Scotland NHS 5 Private 1 England NHS 77 Private 16 N Ireland 3 Wales 3 Total 105
10 UK Interventional and Diagnostic centres 2009 NHS Interventional Private Interventional Diagnostic only No. TOTAL 181 No cath data No PCI data na Caths (% of total) PCIs (% of total) Aggregate forms
11 UK Interventional and Diagnostic centres 2009 NHS Interventional Private Interventional Diagnostic only No. TOTAL 181 No cath data No PCI data na Caths (% of total) PCIs (% of total) Aggregate forms
12 UK Interventional and Diagnostic centres No. Royal Gwent NHS Interventional Private Interventional Diagnostic only TOTAL 181 No cath data 2009 No PCI data NO DATA PROVIDED Huddersfield Royal Infirmary Princess Royal University Royal Surrey County South Tyneside District 76 5 na Caths (% of total) Dr S Ikram PCIs (% of total) Dr RN Stevenson Dr S Kawatowski Dr E Leatham Dr A Nasser Aggregate forms
13 UK Interventional and Diagnostic centres NHS Interventional Private Interventional Diagnostic only # No cath data 2009 No PCI data Caths PCIs ,294 81, ,256 1, ,703 - TOTAL ,253 83,130 Aggregate forms
14 PCI activity to 2009 (UK) PCI per million PCI Procedures ,331 83, PCI per million , PCI Procedure Numbers Aggregate forms
15 Rate of increase in PCI numbers pmp Rate of Increase (%) Aggregate forms
16 PCI per Angiogram ratio % Aggregate forms
17 PCI per Angiogram ratio By Individual PCI Units % Number of PCI procedures
18 Diagnostic only Centres Cath lab utilization Number of Cases per Session Total Number of Diagnostic Angiograms Only fixed labs (no shared or mobile) Does not account for sessions for pacing etc
19 Diagnostic only Centres Cath lab utilization Number of Sessions per Week Total Number of Diagnostic Angiograms Only fixed labs (no shared or mobile) Does not account for sessions for pacing etc
20 Diagnostic only Centres Cath lab utilization No. of Angiograms per cath lab Total Number of Diagnostic Angiograms Only fixed labs (no shared or mobile)
21 Total PCIs in the UK Countries by Type of Institution Total No.s of PCI England NHS England Private Scotland NHS Scotland Private N. Ireland Wales Aggregate forms
22 Total PCIs in the UK Countries by Type of Institution Total No.s of PCI England NHS England Private Scotland NHS Scotland Private N. Ireland Wales Aggregate forms
23 Population estimates Mid 2009 Total UK: 61.8 m Scotland m Northern Ireland m England m est: N. Welsh pop 0.7m 0.45m served locally ( 0.22 for 2009) 0.25m Rx in England ( 0.48 for 2009) Total Rx in England m Wales 2.99 m est: Rx in Wales: 2.74 m
24 PCIs/million UK Countries England Scotland N. Ireland Wales Aggregate forms
25 PCI vs Isolated CABG Numbers (UK) 1991 to PCI CABG Note: CABG data for financial yr Aggregate forms
26 PCI vs Isolated CABG Ratio (UK) 2000 to 2009 Ratio Aggregate forms
27 Number of PCIs performed in 2009 (per NHS Centre) Mean = Number of PCIs Individual Centres 21 Centres performing < 400 cases (20%) Data from: all NHS centres Aggregate forms
28 Number of PCIs performed in Centres performing < 400 procedures St Mary's London (<2002) Lister (2006) Wigan Royal Infirmary (2007) Glan Clwyd (2009) Watford General (2009) Wexham Park (2006) Conquest (2007) Great Western (2006) Torbay (2004) St Peter's (2003) Northampton General (2009) Lincoln County (2008) Eastbourne (2006) Bradford Royal Infirmary (2005) Kings Mill (2008) Kent and Sussex (2008) Frenchay (2008) Whipps Cross (2005) QE Woolwich (2007) Darent Valley (2008) Ealing (2009) PCI program start date
29 No. of Interventional Consultants (NHS centres) Number % Total Increase 0 Note: if work at two NHS centres will be counted twice Includes cardiologists and radiologists
30 No. of Consultant in each unit (NHS Centres 2009) Number of Consultants in each unit Total PCIs in each Unit Note: if work at two NHS centres will be counted twice
31 No. of Consultant in each unit (NHS Centres 2009) Mean Number of Operators per Unit Note: if work at two NHS centres will be counted twice
32 PCI per Consultant Unit case number / Number of operators Number of PCIs
33 No. of PCIs per Consultant (NHS Centres 2009) Total PCIs / Number of Consultants Total PCIs in each Unit Note: Data from institutional volume divided by No operators per institution Some consultants work in multiple institutions
34 On v Off Site Surgery All Centres (NHS and private) 100% 80% Off Site On Site 60% 40% 20% % 0% Aggregate forms
35 On v Off Site Surgery NHS Centres only 100% 80% Off Site On Site 60% 40% 20% % 0% Aggregate forms
36 Surgical Cover ( all NHS centres) Off site On Site PCIs per Centre Mean Median Individual Centres Aggregate forms
37 Surgical Cover (all 105 NHS and Private Centres) On site No of centres 50 (48%) No. of PCI (% of total) 56,548 (71%) Off site 54 (52%) 26,582 (29%) Mean No. PCI per centre (all) Mean No. PCI per centre (NHS) Aggregate forms
38 Day Case PCI 58 of 92 Units performing day case PCI Number % Number % of all PCI Data from: 92 of 105 centres
39 Day Case PCI As Percentage of all PCI activity 2009 Data from 92 of 105 centres % Number of PCI procedures
40 Primary PCI Routine Rx for STEMI Working Hours 24/7 Percentage of NHS Centres 100% 80% 60% 40% 20% 0% NHS Centres only % 80% 60% 40% 20% 0% Number of centres Working Hrs includes all 24/7 sites
41 PPCI 2009 No PPCI PPCI day PPCI 24/7
42 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
43 Procedure Specific Analysis Participation in CCAD Total No. of Centres Data to CCAD England NHS Private 16 5 Wales 3 3 Missing Ealing King Mill QE Woolwich N Ireland 3 2 Scotland NHS 7 6 Private 1 0
44 Procedure Specific Analysis Participation in CCAD Total No. of Centres Data to CCAD England NHS Missing Private 16 5 Wales 3 3 N Ireland 3 2 Belfast City Scotland NHS 7 6 Private 1 0
45 Procedure Specific Analysis Participation in CCAD Total No. of Centres Data to CCAD England NHS Missing Private 16 5 Wales 3 3 N Ireland 3 2 Scotland NHS 7 6 Hairmyres Private 1 0
46 Procedure Specific Analysis Participation in CCAD Total No. of Centres Data to CCAD Participation England NHS % Private % Wales % N Ireland % Scotland NHS % Private 1 0 0%
47 Front end Database used BCIS Tomcat PATS Medcon Cardaas Lotus Notes Datacam Minerva Cardiobase Infoflex Cardex In house PIMS Prism Xper and Prism Webhiss
48 Data Quantity
49 CCAD data UK PCI data in CCAD as % of Reported Totals YKC. RHH. Capio PHN. Ros Yorkshire LNH. LEB. Leeds MHO. BMI s HBP. IND. BUPA London KMH. BUPA Nuffield Manor Park Hall Clinic, Independent Kings HosMill pital Leeds GWH. Queen HAI. Hairm Hull & CBS. BUPA CRO. EAL. Elizabeth yres East BMI. Crom Ealing Hos Riding AHM. BFT. BMI ANT. PHB. BMI Belfast Meriden Southam well pital, BAT. CRG. Royal ESU. St BMI Alexandra City QAP. NPH. Craigavon United East Anthony's Priory pton Surrey RIA. RVB. BAL. Queen Northwick HAM. Aberdeen Royal Barts Alexandra Park Area Hos pital Bath Victoria the SGH. Southam GEO. Ham NCR. pton St m George's ersm Royal ith Infirm London PMS. KCH. The RFH. New General King's Great Royal Cros Western Free s ary SUN. WAT. Sunderland FRY. Frenchay College Watford RSC. Royal WDH. WRG. CLW. DVH. Suss Dorset Worthing General Royal BRI. HSC. Glan Darent ex County Bris Harley Clwyd Valley CHG. NOR. Cheltenham CHH. TOR. DUD. tol Royal Street DGH Castle Torbay City Infirm Clinic Trust ary NGS. Norfolk Northern & Norwich General Hill EBH. UHW. Birm ingham FRE. STO. WEX. University Heartlands Freem General an NHH. North Wexham North Staffordshire Park of WHH. MOR. Ham William Morris pshire BHR. Royal MAY. Berks Mayday PLY. BRD. GJH. Golden PAP. hire and University Derriford Harvey ton Wales Papworth Battle Bradford Jubilee STH. HH. St Harefield Royal Infirm WRC. RDE. Worcestershire Royal Devon LIS. Thom & Exeter Lister as ' ary UCL. University VIC. SCM. Jam NTH. QEB. es Northam Queen Cook SPH. STM. University St St College Victoria Royal Peter's Mary's KGH. KSX. NIN. pton Elizabeth Kettering Kent Ninewells General & FRM. GRL. CHN. DER. DGE. Frim Glenfield General Suss ex BHL. Liverpool BOU. Royal CGH. Nottingham Derby Eas ley Park Royal tbourne Heart Bournem Conques City Infirm DGH BHH. and MRI. WYT. Manches BAS. Rochdale Ches outh t ary t LIN. LGI. Wythenshawe ter Bas Royal ildon Infirm General Infirm ary MPH. Lincoln Yorkshire SAN. Sandwell HHW. Taunton County Heart ary AMG. Wycom District Wellington & Som Centre WHC. Whipps ERI. NHB. Royal Cros WAL. be General ers et AEI. RCH. RAD. Royal infirm s Walsgrave University LBH. Royal Royal John Brom ary London Albert Cornwall Radcliffe pton of Edinburgh Edward Bridge Infirm ary As August
50 CCAD data UK PCI data in CCAD as % of Reported Totals YKC. RHH. Capio PHN. Ros Yorkshire LNH. LEB. Leeds MHO. BMI s HBP. IND. BUPA London KMH. BUPA Nuffield Manor Park Hall Clinic, Independent Kings HosMill pital Leeds GWH. Queen HAI. Hairm Hull & CBS. BUPA CRO. EAL. Elizabeth yres East BMI. Crom Ealing Hos Riding AHM. BFT. BMI ANT. PHB. BMI Belfast Meriden Southam well pital, BAT. CRG. Royal ESU. St BMI Alexandra City QAP. NPH. Craigavon United East Anthony's Priory pton Surrey RIA. RVB. BAL. Queen Northwick HAM. Aberdeen Royal Barts Alexandra Park Area Hos pital Bath Victoria the SGH. Southam GEO. Ham NCR. pton St m George's ersm Royal ith Infirm London PMS. KCH. The RFH. New General King's Great Royal Cros Western Free s ary SUN. WAT. Sunderland FRY. Frenchay College Watford RSC. Royal WDH. WRG. CLW. DVH. Suss Dorset Worthing General Royal BRI. HSC. Glan Darent ex County Bris Harley Clwyd Valley CHG. NOR. Cheltenham CHH. TOR. DUD. tol Royal Street DGH Castle Torbay City Infirm Clinic Trust ary NGS. Norfolk Northern & Norwich General Hill EBH. UHW. Birm ingham FRE. STO. WEX. University Heartlands Freem General an NHH. North Wexham North Staffordshire Park of WHH. MOR. Ham William Morris pshire BHR. Royal MAY. Berks Mayday PLY. BRD. GJH. Golden PAP. hire and University Derriford Harvey ton Wales Papworth Battle Bradford Jubilee STH. HH. St Harefield Royal Infirm WRC. RDE. Worcestershire Royal Devon LIS. Thom & Exeter Lister as ' ary UCL. University VIC. SCM. Jam NTH. QEB. es Northam Queen Cook SPH. STM. University St St College Victoria Royal Peter's Mary's KGH. KSX. NIN. pton Elizabeth Kettering Kent Ninewells General & FRM. GRL. CHN. DER. DGE. Frim Glenfield General Suss ex BHL. Liverpool BOU. Royal CGH. Nottingham Derby Eas ley Park Royal tbourne Heart Bournem Conques City Infirm DGH BHH. and MRI. WYT. Manches BAS. Rochdale Ches outh t ary t LIN. LGI. Wythenshawe ter Bas Royal ildon Infirm General Infirm ary MPH. Lincoln Yorkshire SAN. Sandwell HHW. Taunton County Heart ary AMG. Wycom District Wellington & Som Centre WHC. Whipps ERI. NHB. Royal Cros WAL. be General ers et AEI. RCH. RAD. Royal infirm s Walsgrave University LBH. Royal Royal John Brom ary London Albert Cornwall Radcliffe pton of Edinburgh Edward Bridge Infirm ary As August 2010 No Data
51 CCAD data UK PCI data in CCAD as % of Reported Totals YKC. Capio Yorkshire Clinic RHH. Ross Hall PHN. BMI Park MHO. Manor LNH. Leeds Nuffield LEB. BUPA Leeds KMH. Kings Mill IND. London Independent HBP. BUPA, Hull & East Riding HAI. Hairmyres GW H. Queen Elizabeth, W oolwich EAL. Ealing CRO. Cromwell CBS. BUPA Southampton BMI. BMI Meriden BFT. Belfast City AHM. BMI Alexandra As August 2010 No Data
52 CCAD data UK PCI data in CCAD as % of Reported Totals YKC. RHH. Capio PHN. Ros Yorkshire LNH. LEB. Leeds MHO. BMI s HBP. IND. BUPA London KMH. BUPA Nuffield Manor Park Hall Clinic, Independent Kings HosMill pital Leeds GWH. Queen HAI. Hairm Hull & CBS. BUPA CRO. EAL. Elizabeth yres East BMI. Crom Ealing Hos Riding AHM. BFT. BMI ANT. PHB. BMI Belfast Meriden Southam well pital, BAT. CRG. Royal ESU. St BMI Alexandra City QAP. NPH. Craigavon United East Anthony's Priory pton Surrey Hos RIA. RVB. BAL. Queen Northwick HAM. Aberdeen Royal Barts Alexandra Park Area pital Bath Victoria the SGH. Southam GEO. Ham NCR. pton St m George's ersm Royal ith Infirm London PMS. KCH. The RFH. New General King's Great Royal Cros Western Free s ary SUN. WAT. Sunderland FRY. Frenchay College Watford RSC. Royal WDH. WRG. CLW. DVH. Suss Dorset Worthing General Royal BRI. HSC. Glan Darent ex County Bris Harley Clwyd Valley CHG. NOR. Cheltenham CHH. TOR. DUD. tol Royal Street DGH Castle Torbay City Infirm Clinic Trust ary NGS. Norfolk Northern & Norwich General Hill EBH. UHW. Birm ingham FRE. STO. WEX. University Heartlands Freem General an NHH. North Wexham North Staffordshire Park of WHH. MOR. Ham William Morris pshire BHR. Royal MAY. Berks Mayday PLY. BRD. GJH. Golden PAP. hire and University Derriford Harvey ton Wales Papworth Battle Bradford Jubilee STH. HH. St Harefield Royal Infirm WRC. RDE. Worcestershire Royal Devon LIS. Thom & Exeter Lister as ' ary UCL. University VIC. SCM. Jam NTH. QEB. es Northam Queen Cook SPH. STM. University St St College Victoria Royal Peter's Mary's KGH. KSX. NIN. pton Elizabeth Kettering Kent Ninewells General & FRM. GRL. CHN. DER. DGE. Frim Glenfield General Suss ex BHL. Liverpool BOU. Royal CGH. Nottingham Derby Eas ley Park Royal tbourne Heart Bournem Conques City Infirm DGH BHH. and MRI. WYT. Manches BAS. Rochdale Ches outh t ary t LIN. LGI. Wythenshawe ter Bas Royal ildon Infirm General Infirm ary MPH. Lincoln Yorkshire SAN. Sandwell HHW. Taunton County Heart ary AMG. Wycom District Wellington & Som Centre WHC. Whipps ERI. NHB. Royal Cros WAL. be General ers et AEI. RCH. RAD. Royal infirm s Walsgrave University LBH. Royal Royal John Brom ary London Albert Cornwall Radcliffe pton of Edinburgh Edward Bridge Infirm ary As August 2010 < 90%
53 CCAD data UK PCI data in CCAD as % of Reported Totals PHB. BMI Priory ANT. St Anthony's ESU. East Surrey < 90% BAT. Royal United Bath CRG. Craigavon Area NPH. Northwick Park QAP. Queen Alexandra BAL. Barts and the London RVB. Royal Victoria RIA. Aberdeen Royal Infirmary HAM. Hammersmith As August
54 CCAD data UK PCI data in CCAD as % of Reported Totals YKC. RHH. Capio PHN. Ros Yorkshire LNH. LEB. Leeds MHO. BMI s HBP. IND. BUPA London KMH. BUPA Nuffield Manor Park Hall Clinic, Independent Kings HosMill pital Leeds GWH. Queen HAI. Hairm Hull & CBS. BUPA CRO. EAL. Elizabeth yres East BMI. Crom Ealing Hos Riding AHM. BFT. BMI ANT. PHB. BMI Belfast Meriden Southam well pital, BAT. CRG. Royal ESU. St BMI Alexandra City QAP. NPH. Craigavon United East Anthony's Priory pton Surrey RIA. RVB. BAL. Queen Northwick HAM. Aberdeen Royal Barts Alexandra Park Area Hos pital Bath Victoria the SGH. Southam GEO. Ham NCR. pton St m George's ersm Royal ith Infirm London PMS. KCH. The RFH. New General King's Great Royal Cros Western Free s ary SUN. WAT. Sunderland FRY. Frenchay College Watford RSC. Royal WDH. WRG. CLW. DVH. Suss Dorset Worthing General Royal BRI. HSC. Glan Darent ex County Bris Harley Clwyd Valley CHG. NOR. Cheltenham CHH. TOR. DUD. tol Royal Street DGH Castle Torbay City Infirm Clinic Trust ary NGS. Norfolk Northern & Norwich General Hill EBH. UHW. Birm ingham FRE. STO. WEX. University Heartlands Freem General an NHH. North Wexham North Staffordshire Park of WHH. MOR. Ham William Morris pshire BHR. Royal MAY. Berks Mayday PLY. BRD. GJH. Golden PAP. hire and University Derriford Harvey ton Wales Papworth Battle Bradford Jubilee STH. HH. St Harefield Royal Infirm WRC. RDE. Worcestershire Royal Devon LIS. Thom & Exeter Lister as ' ary UCL. University VIC. SCM. Jam NTH. QEB. es Northam Queen Cook SPH. STM. University St St College Victoria Royal Peter's Mary's KGH. KSX. NIN. pton Elizabeth Kettering Kent Ninewells General & FRM. GRL. CHN. DER. DGE. Frim Glenfield General Suss ex BHL. Liverpool BOU. Royal CGH. Nottingham Derby Eas ley Park Royal tbourne Heart Bournem Conques City Infirm DGH BHH. and MRI. WYT. Manches BAS. Rochdale Ches outh t ary t LIN. LGI. Wythenshawe ter Bas Royal ildon Infirm General Infirm ary MPH. Lincoln Yorkshire SAN. Sandwell HHW. Taunton County Heart ary AMG. Wycom District Wellington & Som Centre WHC. Whipps ERI. NHB. Royal Cros WAL. be General ers et AEI. RCH. RAD. Royal infirm s Walsgrave University LBH. Royal Royal John Brom ary London Albert Cornwall Radcliffe pton of Edinburgh Edward Bridge Infirm ary As August 2010 UK E&W (NHS) Scotland (NHS) N. Ireland PCIs 83,130 71,277 7,153 3,049 In CCAD 77,578 69,074 5,896 1,577 Missing 5,552 2,203 1,257 1,472 % Missing 6.7% 3.1% 17.6% 48.3%
55 Data Quality
56 Risk Stratified Outcome A D Grayson et al Heart 2006;92: NWQIP risk adjustment model
57 % Completeness 12 fields required for risk adjusted outcome NWQIP Top score potential = 1200
58
59 Demographics Age (mean) 64.3 yrs 64.4 yrs 65.0 yrs Sex (male) 73.6% 73.8% 73.9% Diabetic 17.5% 18.0% 18.2% Previous CABG 8.5% 9.1% 8.6% Previous PCI 18.6% 21.1% 22.3% Previous MI 29.5% 30.2% 28.8% CCAD
60 Demographics - Age Male: mean = 63.7 Female: mean = No. PCIs Male 07 Male 08 Male 09 Female 07 Female 08 Female 09 <= >90 Age (yrs) CCAD
61 Demographics - Age 75 Mean Age(yrs) Number of PCI procedures
62 Demographics Ethnic Origin Year n 43,929 48,581 57,733 Caucasian 92.3% 92.0% 93.0% Asian 6.7% 7.1% 6.16% Black 0.83% 0.72% 0.71% Oriental 0.2% 0.17% 0.15% CCAD
63 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
64 Clinical Syndrome % PCI Performed for each Indication Stable Unstable CCAD
65 Clinical Syndrome % PCI in patients with Acute syndromes by unit volume 100 % Acute cases Number of PCI procedures
66 Indication for PCI 100% % 60% 40% STEMI NSTEMI/UA Stable Other 20% %
67 Indication for PCI 38.28% 20.25% Stable NSTEMI / UA STEMI Other 1.69% 39.78% CCAD
68 Indication for PCI Stable NSTEMI / UA STEMI Other 38.28% 20.25% 1.69% 39.78% CCAD
69 Indication for PCI Other Stable NSTEMI / UA 1.4 STEMI Other % 20.25% 1.69% % % Staged Hybrid SAT Bailout CCAD
70 Indication for PCI Stable NSTEMI / UA STEMI Other 38.28% 20.25% 1.69% 39.78% CCAD
71 PCI for STEMI All STEMI Primary PCI Rescue CCAD
72 Primary PCI for STEMI Absolute number PPCI (2009) Number of PPCI cases Number of any type of PCI procedure
73 Primary PCI for STEMI % PPCI of total activity (2009) % of total PCI Activity Number of any type of PCI procedure
74 Primary PCI UK Countries Total Number of PPCI England Scotland Wales CCAD
75 Primary PCI UK Countries PPCI pmp England Scotland Wales UK Total CCAD
76 Primary PCI European Countries Widimsky P EHJ 2010;31:
77 PPCI Multi-vessel disease Of 13,208 cases Single epicardial territory > 75%: 9163 More than 1 territory > 75%: % PPCI with multi-vessel disease Single vessel PCI 90.1%
78 PPCI Treated Epicardial Territory Number LMS LAD Cx RCA
79 PPCI Treated Epicardial Territory 2% 41% 42% LMS LAD Cx RCA 15%
80 Stents
81 Procedures using Stents % of Procedures '92 '94 '96 '98 '00 '02 '04 '06 '08 Year 92 aggregate data up to 2007, CCAD for 2008 on
82 Procedures using Stents Mean = 92% % PCI with stent Number of PCI procedures CCAD
83 PCI with Drug Eluting Stents Mean of % use by Centres % DES cases ? CCAD
84 PCI with Drug Eluting Stents Mean = 63.5% % PCI with DES Number of PCI procedures
85 PCI with Drug Eluting Stents By Syndrome % DES cases Stable UA / NSTEMI PPCI CCAD
86 Drug Eluting Stent % PCI with DES Scotland England Wales N. Ireland Country Data to 2007 NHS only Data for 2008 and 2009 all units from CCAD
87 Stents per Case Mean number of stents per case CCAD
88 Mean Stents per Case (by PCI unit) 2.5 Stents per case Number of PCI procedures
89 BMS and DES use V PCI for Restenosis '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 ' % PCI with any Stent % PCI with DES % PCI for restenosis
90 Procedures for Restenosis % by total unit activity % PCI for restenosis Number of PCI procedures
91 Adjunctive therapy % of Procedures Any IIb/IIIa antag Abciximab Eptifibatide Tirofiban Bivalirudin Prasugrel
92 GP IIb/IIIa Antagonists Use by Presentation % Procedures w ith any GP IIb/IIIa blocker Stable UA NSTEMI PPCI CCAD
93 LV Support Data for circulatory support available for 71,771 procedures LV Support Number % Inotropes % % IABP % %
94 LV Support % IABP use by total unit activity % IABP used Number of PCI procedures
95 Cardiogenic Shock % Cases with shock by PCI unit Shock in 1.8% of cases (1416 of 77,660)
96 Cardiogenic Shock % Cases with shock by PCI unit Shock in 1.8% of cases (1416 of 77,660)
97 % Shock Cases Treated with IABP support by total PCI unit activity Mean = 50.6% % Shock treated with IABP Total number of PCI procedures
98 LV Support % cases using IABP v LV function Data from 38,939 cases % Good LV Moderate Poor
99 Multi-Vessel Disease
100 Multi-vessel Treatment 100 % of all PCIs Vessels Treated per case
101 Multi-Lesion Treatment % of all PCIs > Number of Lesions treated per case
102 Multi-Lesion Treatment % Lesions per case Vessels per case
103 Additional Interventional Coronary Techniques Units No % cf 2008 Mean* Max Cases Rotablation % Laser % Cutting balloon % Thrombectomy % Distal protection % *Mean number in units using the technique Aggregate data
104 Rotational Atherectomy % of Cases using Rota Total Number of PCI procedures
105 Other Diagnostic Techniques Max Units No cf 2008 Mean Cases IVUS % Press wire %
106 IVUS and Pressure Wire % Cases with device IVUS PW Total Number of PCI procedures
107 Arterial access
108 Radial Artery Access % Cases using Radial Access
109 Radial Artery Access % Cases using radial access Total number of PCI procedures
110 Radial Artery Access Clinical Syndrome % Cases using Radial Access Stable ACS not STEMI PPCI
111 Femoral closure devices % PCI via FA using closure device FA closure (PCI from FA) 2006 = 39.6% 2007 = 50.7% 2008 = 53.6% 2009 = 57.1% % Total Number of PCIs from Femoral Artery
112 Access site complications Complications to hospital Dx: False aneurysm, haemorrhage, arterial occlusion / dissection Any other surgical intervention % of all cases As listed False aneurysm Haemorrhage As listed + all other
113 Complication by Access route Complications to hospital Dx: False aneurysm Haemorrhage (retroperitoneal, delay Dx, surgery) Art occlusion / dissection Any need for surgery % of all cases Femoral Radial
114 Complication by Access route CVA 0.2 % Cases with CVA Femoral Radial
115 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
116 Time Delays to Treatment
117 Time fields Data completeness For Healthcheck 09/10 BCIS Field No. Patients treated for STEMI by Primary PCI MINAP Field No Date/time of symptom onset Date/time of arrival at first hospital Date/time of arrival at PCI hospital 3.26 Date/time of first balloon inflation Discharge date 4.01 > 90% completeness in each
118 Time fields Data completeness
119 Time fields Data completeness
120 Time fields Data completeness
121 Primary PCI
122 Primary PCI 2009: Rx for STEMI (NHS centres) Funnel analysis for TIMING DELAYS all units performing > 10 cases of PPCI (patients with onset of symptoms in the community) Excludes patients in cardiogenic shock Excludes those needing pre-pci ventilation
123 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Already in hospital Admission to Non-PCI centre Direct admission to PCI centre Transfer to PCI centre is a PCI centre is a Non-PCI centre
124 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Already in hospital Admission to Non-PCI centre Direct admission to PCI centre Transfer to PCI centre
125 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
126 Primary PCI Direct and IHT: Call to Balloon times < 150 min % CTB < 150 min 75.3% Number of Cases
127 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
128 Primary PCI Direct and IHT: PCI Door to Balloon < 90 min 87.3% % DTB < 90 min Number of Cases
129 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 D2 Direct admission to PCI centre V Transfer to PCI centre device
130 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
131 Primary PCI Direct: Call to Balloon times < 150 min 85.1% % CTB < 150 min Number of Cases
132 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
133 Primary PCI IHT: Call to Balloon times < 150 min % CTB < 150 min 45.1% Number of Cases
134 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 D2 Direct admission to PCI centre V Transfer to PCI centre device
135 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
136 Primary PCI IHT: PCI Door to Balloon times < 90 min 92.2% % DTB < 90 min Number of Cases
137 PCI for Acute Sx Four admission scenarios 2009 data: Ludman Admitted from the community Admission to Non-PCI centre D1 Direct admission to PCI centre Transfer to PCI centre D2 device
138 Primary PCI Direct: Door to Balloon times < 90 min % DTB < 90min 85.6% Number of Cases
139 Primary PCI Summary % Cases CTB < 150 min DTB < 90 min 20 0 All Direct IHT
140 Primary PCI Summary 26.1% IHT v 73.9% Direct % Cases CTB < 150 min DTB < 90 min 20 0 All Direct IHT
141 PPCI circadian analysis 2009 data All cases with the PCI indication recorded as Primary PCI Includes shock, ventilation Only exclusions where there are missing date/time fields
142 Primary PCI procedures Time of first device Total 12,141 Total 10,173 16% Rx in day time only centres
143 Primary PCI procedures Time of first device 19:00 to 07:00 = 12 /day 23:00 to 06:00 = 7 /day Total 12,141 NB: +20% false activation + variability
144 PPCI Call to Balloon time IHT and Direct admissions 140 Median CTB: All centres Mins Median= Hour of Day Number Number of Cases: All centres Hour of Day Includes shock and ventilation
145 PPCI Call to Balloon time IHT and Direct admissions Median CTB: 24-7 centres Mins Hour of Day 700 Number of Cases: 24-7 centres Number Includes shock and ventilation Hour of Day
146 PPCI Call to Balloon time Direct only Mins Number Median CTB: All centres Number of Cases: All centres Median=106 min Hour of Day Hour of Day Includes shock and ventilation
147 PPCI Call to Balloon time Direct only Includes shock and ventilation
148 PPCI Call to Balloon time IHT only Median=161min Includes shock and ventilation
149 PPCI Call to Balloon time IHT only Includes shock and ventilation
150 PPCI Call to Balloon time By Admission Route 250 Median CTB min (+/- IQR) Direct IHT ALL Includes shock and ventilation
151 PPCI Door to Balloon Time Direct Admissions Median 47 min (IQR 27-74)
152 PPCI Door to Balloon Time IHT Median 30 min (IQR 22-55)
153 PPCI Door to Balloon time By Admission Route Median DTB min (+/- IQR) Direct IHT ALL Includes shock and ventilation
154 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
155 Adult Non Coronary Intervention
156 Alcohol Mediated Septal Ablation Units No cf 2008 Mean Max Septal ablation % Number of Procedures Individual Centres
157 Adult non coronary intervention Units No. cf 2008 Mean Max Cases MV plasty % AV plasty % PV plasty % TV plasty PDA % ASD PFO %
158 PFO Closure 120 Number of Procedures Individual Centres
159 Adult non coronary intervention Units No cf 2008 Mean VSD congen % 2 5 VSD post MI % LAA occlusion Paravalvular leak closure Max % 3.6 6
160 Adult great vessel intervention Units No cf 2008 Mean Max Coarct / Re-coart % 8 17 Carotid % Aorta % 8 12 Pulm art % 4 8
161 Transcatheter Valves Units No Mean Max Cases Transcatheter Aortic Valve Implantation (TAVI) CoreValve: Femoral CoreValve: Subclavian Edwards: Femoral Edwards: Apical Total = 551
162 UK TAVI Centres TAVI Cases to Dec 31 st 2009 Royal Brompton 114 St Thomas s 102 Glenfield 85 King's College 71 Royal Sussex County 63 Leeds General Infrmy 48 Wythenshawe 48 St George's 44 Bristol Royal Infrmy 43 (Royal Victoria, Belfast 43) John Radcliffe 29 Liverpool Heart and Chest 27 Hammersmith 27 Victoria 24 New Cross 23 Papworth 23 Barts and the London 22 Freeman 12 Southampton General 11 North Staffs 11 Queen Elizabeth 10 Derriford 9 James Cook 8 Manchester Royal Infrmy 7 London Bridge 6 Morriston 5
163 26 Centres 872 Patients Additional 43 cases from Belfast not included in any further analyses
164 UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry 100% of consecutive UK TAVI implants 1 st Jan 2007 to 31 st Dec 2009 Mortality tracking linkage of central TAVI database with the Office of National Statistics (ONS) 872 TAVI procedures 862 successful valve implants, 10 unsuccessful Data as Additional 43 cases from Belfast not included
165 UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry Number of TAVI by year Data as
166 UK TAVI Registry The United Kingdom Transcatheter Aortic Valve Implantation Registry Number of Valves Implanted undeployed device in 10 cases Medtronic CoreValve (n=460) Edwards Sapien (n=402) 3 Unknown Other* Transapical Transfemoral Data as *41 subclavian, 2 other
167 UK TAVI Registry Demographics Data as All Male 52% Age median (IQR) yr 83 (78-87) Age range (yr) Diabetes 23% Prior CABG 26% PVD 32% CAD 48% LMS disease 5.6%
168 UK TAVI Registry Demographics Data as All Transfemoral Other routes Male 52% 52% 54% p=ns Age median (IQR) yr 83 (78-87) 83 (78-87) 83 (79-87) p=ns Age range (yr) Diabetes 23% 23% 23% p=ns Prior CABG 26% 23% 33% p=0.002 PVD 32% 23% 51% p< CAD 48% 44% 57% P< LMS disease 5.6% 4.6% 8.0% p=ns
169 UK TAVI Registry Demographics Data as All Transfemoral Other routes Male 52% 52% 54% p=ns Age median (IQR) yr 83 (78-87) 83 (78-87) 83 (79-87) p=ns Age range (yr) Diabetes 23% 23% 23% p=ns Prior CABG 26% 23% 33% p=0.002 PVD 32% 23% 51% p< CAD 48% 44% 57% P< LMS disease 5.6% 4.6% 8.0% p=ns
170 100% UK TAVI Registry Demographics Data as % 80% 70% 60% 50% 40% 30% 20% 10% 0% All Transfemoral Other routes NYHA I NYHA II NYHA III NYHA VI All Transfemoral Other routes Angina 43% 44% 39%
171 UK TAVI Registry Case Mix Data as All Peak AV gradient (mmhg) 80 Valve Area (cm 2 ) 0.68 LVEF>50% 64% LVEF < 30% 8% Logistic EURO Score 21.6%
172 UK TAVI Registry Case Mix Data as All Transfemoral Other routes Peak AV gradient (mmhg) p=ns Valve Area (cm 2 ) p=ns LVEF>50% 64% 65% 63% p=ns LVEF < 30% 8% 7% 9% p=ns Logistic EURO Score 21.6% 20.3% 24.5% P<0.01
173 UK TAVI Registry Case Mix Data as All Transfemoral Other routes Peak AV gradient (mmhg) p=ns Valve Area (cm 2 ) p=ns LVEF>50% 64% 65% 63% p=ns LVEF < 30% 8% 7% 9% p=ns Logistic EURO Score 21.6% 20.3% 24.5% P<0.01
174 UK TAVI Registry In Outcomes % Non Hierarchical MACCE All Transfemoral Other Routes Data as Breakdown 54 (6.2%) of patients died 88 (10.1%) died or had MI or CVA 10 died subsequent to CVA or MI 34 had CVA or MI and survived 0 Death MI CVA Other MACCE All Transfemoral Other routes TIA 0.6% 0.3% 1.1% Emergency Surgical AVR 0.7% 0% 2.2%
175 UK TAVI Registry In Outcomes Data as Edwards Sapien Medtronic CoreValve Transfemoral Other route p< p= p=ns 5 p= Major Vascular Complication* Pacemaker 0 Major Vascular Complication* Pacemaker *Major vascular injury or later vascular injury requiring surgery
176 UK TAVI Centres Mortality tracking to Dec 31 st 2009 TAVI (intention to Rx) n=872 Mortality tracked by ONS n=842 Not ONS tracked: life status reported at 1 year or discharge n=30 Not tracked Unknown outcome n=0 Tracking Survival curves based on n=872
177 UK TAVI Registry Overall Survival Data as Median FU: 330 days 0 30/7 6/12 1 yr 18/12 2 yr Survival 93.1% 84.4% 80.3% 77.6% 75.1% n at risk
178 UK TAVI Registry Data as Transfemoral Other p= cases route unknown 0 30/7 6/12 1 yr 18/12 2 yr Survival: Transfemoral 94.8% 86.5% 82.4% 80.4% 78.3% Number at risk Survival: Other routes 89.1% 79.6% 75.5% 71.1% 66.5% Number at risk
179 UK TAVI Registry Data as Medtronic Corevalve Edwards Sapien p=n.s. 10 cases no valve deployed 0 30/7 6/12 1 yr 18/12 2 yr Survival: CoreValve 94.5% 86.3% 81.6% 79.8% 77.6% Number at risk Survival: Edwards Sapien 91.1% 82.7% 79.5% 75.6% 72.2% Number at risk
180 UK TAVI Registry Minimising the learning curve? Data as Unproctored case Subsequent cases Proctored case First 20 cases p=n.s. p=n.s.
181 UK TAVI Registry Data as Log Euroscore 0-20% Log Euroscore 20-40% Log Euroscore >40% P= /7 1 yr 18/12 2 yr ES 0-20% n at risk ES 20-40% n at risk ES > 40% n at risk
182 UK TAVI Registry Conclusion Successful implementation of a National dataset UK wide data collection All procedures prospectively captured Incorporates complete experience of all centres including the proctored learning curves Collaboration between all involved Mortality tracking Encouraging early results In hospital mortality: 6.2% 30/7 mortality: 6.9% 1 yr mortality: 19.7%
183 Percutaneous Valves Units No % cf 2008 Mean Max Pulmonary Valve % 7 14
184 Percutaneous Valves - Mitral Units No % cf 2009 Mean Max Cases Mitral Valve Repair Mitra-clip % Viacor 0 Carillon 0 Monarch Total = 35
185 Structure New centres Total PCI numbers No of PCIs per unit and per angio Diagnostic cath lab utilization PCI pmp and by country PCI activity by centre PCI Operators Surgical cover Day case activity Primary PCI units PCI Procedure specific data CCAD data completeness and quality Databases used for collection Demographics Appropriateness Indication for PCI / Clinical syndrome PPCI activity (by unit, pmp, by vessel) Stents (BMS and DES) Adjunctive therapy LV support Shock Multi-vessel treatment Additional interventional techniques Arterial access routes complications Contents Process of care Delays data completeness Delays to treatment Primary PCI CTB times by unit / by admit route DTB times by unit / by admit route Circadian distribution Treatment times Treatment delays Non coronary intervention HOCM septal ablation Transcatheter Aortic Valve Implantation UK TAVI Registry Other adult structural intervention Outcome MACCE Outcome by syndrome ONS tracked mortality PPCI / Rescue / Shock Outcome by lesion subset ONS tracked mortality CTO / ulms Risk adjusted outcomes
186 Outcome
187 Data sources Success, Mortality CVA and Emergency CABG QMI Denominator: Total PCI procedures except PCI for STEMI NQMI Denominator: Total PCIs for stable symptoms
188 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 3
189 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 3 CCAD mortality counts Identifies multiple procedures and only counts one death
190 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 3 Kaplan Meier Survival Subsequent procedures reclassified as re-pci
191 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 30 days 30 days
192 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 30 days 30 days 30/7 death
193 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 30 days 30 days 30/7 death 30/7 survivor
194 Methodology Multiple procedures mortality PCI PCI 1 yr PCI Death 30 days 30 days 30/7 death Censored 30/7 survivor
195 MACE - All PCIs Year Procedure Success (%) QMI % NQMI (stable) (%) Em CABG (%) CVA (%) Mortality (%) 30 day Mortality (%) (from ONS)
196 Adverse Outcomes - Death Mortality to Discharge (self reported) Overall mean = 1.21 % % Number of PCI procedures
197 Adverse Outcomes - Death 30/7 ONS tracked mortality Overall mean = 2.0 % % Number of PCI procedures
198 Adverse Outcomes - CVA % of all cases with CVA (not TIA) Overall mean = 0.08 % % Number of PCI procedures
199 Adverse Outcomes CABG % of all cases needing emergency CABG Overall mean = 0.08 % % Number of PCI procedures
200 Adverse Outcome Death and emergency CABG '91 '92 '93 '94 '95 '96 '97 '98 '99 '00 '01 '02 '03 '04 '05 '06 '07 '08 '09 % Mortality em CABG
201 Peri-procedural Complications
202 Outcome 2009 Elective Patients All as % No. cases Success Partial success Fail no comp Re- PCI QMI Em CABG CVA Death Stable SV (no CTO) MV (no CTO) 19, SV CTO MV CTO OVERALL STABLE All Stable
203 Outcome 2009 All as % No. Success Partial success Fail no comp Re-PCI QMI Em CABG CVA Death In hosp Death 30/7 ONS NSTEMI / UA no shock All STEMI no shock 26, , *Primary PCI 13, *Rescue PCI 1, Shock *all PPCI (includes shock / ventilation etc)
204 Summary: Mortality Risk Stratified by Syndrome 6 % All Elective UA / NSTEMI Primary PCI Rescue
205 Summary: Mortality Risk Stratified by Syndrome 40 % All Elective UA / NSTEMI 4.3 Primary PCI Rescue Shock
206 Primary PCI (excludes shock/vent) Mortality to Discharge (self reported) % Mortality to Discharge 2.3% Number of PPCI procedures Shock and ventilation excluded
207 Primary PCI (excludes shock/vent) 30 day ONS tracked Mortality 2009 data: Ludman % Mortality at 30 days Number of PPCI procedures Shock and ventilation excluded
208 Primary PCI (excludes shock/vent) 30 day ONS tracked Mortality % Mortality at 30 days 3.4% Number of PPCI procedures Shock and ventilation excluded
209 Primary PCI (includes shock/vent) 30 day ONS tracked Mortality 2009 data: Ludman % Mortality at 30 days 6.2% Number of PPCI procedures Shock and ventilation INCLUDED
210 Primary PCI ONS Tracked Mortality of 2008 data Time 0 30/7 6/12 1 yr Mortality 5.7% 7.5% 9.0% Number at risk Shock and ventilation Included
211 Primary PCI (>80yrs) ONS Tracked Mortality of 2008 data 11.5% PPCI in patients 80 yr 0 30/7 6/12 1 yr Mortality: Age >= % 20.3% 24.8% Number at risk Mortality: Age < % 5.9% 6.9% Number at risk Shock and ventilation Included
212 Primary PCI % cases over 80 (2008 data) % of cases with age over 80 yrs 11% Number of PPCI procedures
213 Primary PCI -? Case selection % Cases over 80 (2009 data) % of cases with age over 80 yrs 11.7% Number of PPCI procedures
214 Primary PCI -? Case selection % Cases over 80 (2009 data) % of cases with age over 80 yrs 11.7% Number of PPCI procedures
215 Primary PCI (Shock) ONS Tracked Mortality of 2008 data 6.2% PPCI in Shock 0 30/7 6/12 1 yr Mortality: Shock 42.7% 48.0% 50.2% Number at risk Mortality: No Shock 3.2% 4.9% 6.3% Number at risk Shock and ventilation Included
216 Primary PCI (Diabetes) ONS Tracked Mortality of 2008 data 13.2% PPCI in Diabetics 0 30/7 6/12 1 yr Mortality: Diabetic 8.1% 12.8% 15.9% Number at risk Mortality: No Diabetes 5.3% 7.1% 8.3% Number at risk Shock and ventilation Included
217 Bypass grafts PCI of SVG and Arterial 2009 All as % No. Success Partial success Fail no comp Re- PCI QMI Em CABG In Hosp Death 30/7 Death Centre x = 1860 of 2111 cases in 2008
218 Bypass Grafts (all types - SVG and IMA etc) 2008 Distal protection in 16.8% % 100% % 60% 40% Distal protection used No distal protection 20% 0% Exclude centre x from 2008 calc
219 Chronic Total Occlusions 2009 Inadequate data cleaning for previous analyses Current analysis excludes any CTO performed in context of acute coronary syndrome
220 Chronic Total Occlusions 2009 Analysis From complete 2009 BCIS dataset Number of CTO attempted > Clinical Syndrome = stable 3928 Life Status tracked via ONS 3569 Analysis
221 Chronic Total Occlusions 2009 Demographics All 2009 CTO 2009 Age (mean) 65.0 yrs 63.9 yrs Sex (male) 73.9% 79.8% Diabetic 18.2% 21% Previous CABG 8.6% 30% Previous PCI 22.3% 33% Previous MI 28.8% 45.3%
222 Chronic Total Occlusions 2009 Of 2,739 single vessel treatment Graft 2% Cx 18% LAD 30% RCA 50%
223 Chronic Total Occlusions 2008 Data with ONS track to May 2010 Time 0 30/7 6/12 1 yr Mortality 0.5% 1.3% 2.7% Number at risk
224 Chronic Total Occlusions 2008 Data with ONS track to May 2010 PCI Success PCI Failure 0 30/7 6/12 1 yr Mortality: PCI Success 0.4% 0.9% 1.8% Number at risk Mortality: PCI failed 0.7% 2.1% 3.7% Number at risk
225 Unprotected LMS Including Shock and STEMI All as % No. Success Partial success Fail no comp Re- PCI QMI Em CABG In Hosp Death Death 30/7 (ONS)
226 Unprotected LMS Total number of PCIs % for Rx of ulms
227 Unprotected LMS 2008 Data with ONS track to May 2010 Excluding Shock, PPCI, PH CABG Total 840 patients Demographics All 2009 ulms 2008 Age (mean) 65.0 yrs 70.0 yrs Diabetic 18.2% 20.6% Previous PCI 22.3% 25.7% Previous MI 28.8% 40.0%
228 Unprotected LMS 2008 Data with ONS track to May 2010 Time 0 30/7 6/12 1 yr Mortality 5.4 % 9.3 % 12.4% Number at risk
229 Unprotected LMS 2008 Data with ONS track to May /7 6/12 1 yr Mortality: Stable 2.9% 5.2% 6.6% Number at risk Mortality: UA / NSTEMI 7.8 % 13.4% 18.1% Number at risk
230 Risk Adjusted Outcome
231 Assessment of unit specific performance data Cumulative Funnel Plots for each unit Plots of each unit s overall risk adjusted outcome
232 NWQIP Model Observed MACCE Predicted MACCE +3 σ +2 σ -2 σ -3 σ
233 Outcome MACCE for 2007, 2008 and 2009 After all PCIs for 2007, 2008 and 2009 Risk Adjusted MACCE (for unit x) = Observed MACCE (all cases) X Observed MACCE Predicted MACCE (for unit x)
234 Outcome Data for 2007, 2008 and 2009 % MACCE Observed MACCE = 1.4% Mean 1.37% Number of PCI procedures
235 Outcome Data for 2007, 2008 and 2009 Risk Adjusted MACCE % MACCE Number of PCI procedures
BCIS Audit Returns Adult Interventional Procedures
BCIS Audit Returns Adult Interventional Procedures Jan 2007 to Dec 2007 Peter F Ludman BCIS National Audit Lead On behalf of British Cardiovascular Intervention Society Crewe 2008 Contents Structure New
More informationPeter F Ludman BCIS National Audit Lead
Peter F Ludman BCIS National Audit Lead On behalf of British Cardiovascular Intervention Society Basingstoke October 2015 Contents Structure Angio and PCI centres and maps Total angio and PCI numbers No
More informationPeter F Ludman BCIS National Audit Lead
Peter F Ludman BCIS National Audit Lead On behalf of British Cardiovascular Intervention Society NO CONFLICT OF INTEREST TO DECLARE Data Sources 1. Structure 2. PCI procedure and outcome Cleaning analysis
More informationBCIS Audit Returns of Interventional Procedures 2000
BCIS Audit Returns of Interventional Procedures 2 Southampton, October 21 Mark de Belder BCIS UK National Audit Officer on behalf of Council of the British Cardiovascular Intervention Society UK Intervention
More informationTitle. British Cardiovascular Intervention Society. National Audit of Percutaneous Coronary Interventional Procedures Public Report
Title British Cardiovascular Intervention Society National Audit of Percutaneous Coronary Interventional Procedures Public Report Annual Public Report January 2011 - December 2011 January 2011-December
More informationRisk stra)fica)on: The UK cardiothoracic experience
Risk stra)fica)on: The UK cardiothoracic experience Graeme L Hickey 1 ; Stuart W Grant 2 ; Iain Buchan 1 ; Ben Bridgewater 1,2 1 Northwest Ins.tute of BioHealth Informa.cs, Manchester University 2 Department
More informationMasterclass III Advances in cardiac intervention. Percutaneous valvular intervention a novel approach
Masterclass III Advances in cardiac intervention Percutaneous valvular intervention a novel approach Professor Roger Boyle CBE National Director for Heart Disease and Stroke London Medical therapy Medical
More informationEast Midlands Cardiac and Stroke Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationSussex Heart Network. David Cunningham Director, Central Cardiac Audit Database. Richard Charles Chairman, Network Device Survey Group
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationNational Intervention Council
National Intervention Council Cardiological Society of India Registry Performa for Coronary, Non- Coronary & Peripheral Interventions Period January 1st 2016 to December 31 st 2016 Dr. (Prof.) N.N. Khanna
More informationEssex Cardiac and Stroke Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationAnglia Stroke and Heart Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationNational Haemoglobinopathy Registry. Annual Report 2017/18
National Haemoglobinopathy Registry Annual Report 2017/18 National Haemoglobinopathy Registry Annual Report (2017/18) Compiled by Mark Foster MDSAS 3 1 Introduction CHAPTER 1 The 2017/18 Annual Report
More informationQuality Standards for Patients Treated by PCI. Peter F Ludman
Quality Standards for Patients Treated by PCI Peter F Ludman NO CONFLICT OF INTEREST TO DECLARE Quality Standards for Patients treated by PCI Caution about standards Overall Structure for assessing outcomes
More informationDorset Cardiac Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationThis House believes that coronary angioplasty should take place in a limited number of high volume centres: avoiding the American example.
This House believes that coronary angioplasty should take place in a limited number of high volume centres: avoiding the American example. Volume vs outcome Primary PCI Surgical cover off site vs on site
More informationLessons learned From The National PCI Registry
Lessons learned From The National PCI Registry w a v e On Behalf of The Publication Committee of the National PCI Registry Objectives & Anticipated Achievements To determine the epidemiology of patients
More informationSentinel Stroke National Audit Programme (SSNAP) Based on stroke patients admitted to hospital for thrombectomy between April 2016 and March 2017
Thrombectomy Sentinel Stroke National Audit Programme (SSNAP) Thrombectomy Report for April 2016 - March 2017 National results July 2017 Based on stroke patients admitted to hospital for between April
More informationNational Haemoglobinopathy Registry. Annual Report 2015/16. mdsas
National Haemoglobinopathy Registry Annual Report 2015/16 mdsas National Haemoglobinopathy Registry Annual Report (2015/16) 3 1 Introduction CHAPTER 1 This 2015/16 data update follows the same format as
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationNew Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.)
A. ADMINISTRATIVE New Jersey Cardiac Catheterization Data Registry, Version 2.0 (Please report data only for patients 16 years or older.) 1. Facility Code: 2. Facility Name: 3. Procedure Type (Choose only
More informationThe CREST Trial. Funded by Cancer Research UK and developed by the National Cancer Research Institute
The CREST Trial A randomised phase III study of stenting as a bridge to surgery in obstructing colorectal cancer. Results of the UK ColoRectal Endoscopic Stenting Trial (CREST). Funded by Cancer Research
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationClinical Oncology UK Workforce Report 2012 Faculty of Clinical Oncology
www.rcr.ac.uk Clinical Oncology UK Workforce Report 2012 Faculty of Clinical Oncology www.rcr.ac.uk Contents Foreword 3 1. Introduction and objectives 4 2. Census methodology 5 3. UK clinical oncology
More informationAudit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Thames Valley Local Area Team
Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Thames Valley Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and managers which
More informationNational Audit of Percutaneous Coronary Interventions. Annual Public Report. Title
Title National Audit of Percutaneous Coronary Interventions Annual Public Report 1 National Audit of Percutaneous Coronary Interventions Annual Report 2015 January 2014 - December 2014 Title NICOR (National
More informationCheshire & Merseyside Cardiac Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationPrince Sultan Cardiac Center Experience Riyadh, Saudi Arabia
Transcatheter Transapical Aortic Valve Implantation Prince Sultan Cardiac Center Experience Riyadh, Saudi Arabia Ahmed Elwatidy, MD,PhD, FRCS S Kassab, MD,S Ahmari, MD, H Amri, MD, H Ismail, MD, A Calafiori,
More information3 years after introduction of TAVI in QEH. Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong
3 years after introduction of TAVI in QEH Michael KY Lee On Behalf of QEH TAVI Heart Team Queen Elizabeth Hospital Hong Kong HA Convention 2014 Introduction Aortic Stenosis most common valvular heart disease
More information2/28/2010. Speakers s name: Paul Chiam. I have the following potential conflicts of interest to report: NONE. Antegrade transvenous transseptal route
Transcatheter Aortic Valve Implantation Asian perspective Speakers s name: Paul Chiam Paul TL Chiam MBBS, MRCP, FACC I have the following potential conflicts of interest to report: NONE Consultant National
More informationLM stenting - Cypher
LM stenting - Cypher Left main stenting with BMS Since 1995 Issues in BMS era AMC Restenosis and TLR (%) 3 27 TLR P=.282 Restenosis P=.71 28 2 1 15 12 Ostium 5 4 Shaft Bifurcation Left main stenting with
More informationInterventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504
Transcatheter valve-in-valve e implantation for aortic bioprosthetic valve dysfunction Interventional procedures guidance Published: 26 September 2014 nice.org.uk/guidance/ipg504 Your responsibility This
More information22/06/2017. Oxford City. Transcatheter aortic valve replacement 2017 guidelines. 1. First time I have heard about it. 2.
Oxford City Transcatheter aortic valve replacement 2017 guidelines Monday 19 th June Jim Newton Oxford Oxford University Hospitals NHS FT How familiar are you with TAVR? 1. First time I have heard about
More informationNational Audit of Congenital Heart Disease Executive Summary 2009
National Audit of Congenital Heart Disease Executive Summary 2009 Prepared in partnership with: The Healthcare Quality Improvement Partnership (HQIP) promotes quality in healthcare. HQIP holds commissioning
More informationThe optimum time to assess complete clinical response (CR)
The optimum time to assess complete clinical response (CR) following chemoradiation (CRT) using mitomycin C (MMC) or Cisplatin (CisP) with or without Maintenance CisP/5FU in squamous cell carcinoma of
More informationTRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH
TRANSCATHETER AORTIC VALVE IMPLANTATION: PSCC EXPERIENCE DR HUSSEIN ALAMRI PSCC RIYADH Available systems: Edwards (TA and TF) and Core valve. INTRODUCTION 3 4% 0f > 65 y. 30 40% of elderly denied surgery,.
More informationAudit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. North Yorkshire and Humber Local Area Team
Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT North Yorkshire and Humber Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and
More informationPeri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY)
Peri-operative results and complications in 15,964 transcatheter aortic valve implantations from the German Aortic valve RegistrY (GARY) Thomas Walther, Christian W. Hamm, Gerhard Schuler, Alexander Berkowitsch,
More informationAudit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Bath, Gloucestershire, Swindon and Wiltshire Local Area Team
Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Bath, Gloucestershire, Swindon and Wiltshire Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians,
More informationNorth of England Cardiovascular Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationNCVD-PCI Registry. Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association of Malaysia
NCVD-PCI Registry National Cardiovascular Disease Database (NCVD) National Cardiovascular Disease Database (NCVD) Percutaneous Coronary Intervention (PCI) Registry, MALAYSIA c/o National Heart Association
More informationHow to do Primary Angioplasty. - Patients with Cardiogenic Shock
How to do Primary Angioplasty - Patients with Cardiogenic Shock Advanced Cardiovascular Intervention 2011 Dan Blackman Leeds General Infirmary MY CONFLICTS OF INTEREST ARE: Research Grants Medicines Company
More informationOutcomes after Elective Repair of Infra-renal Abdominal Aortic Aneurysm. A report from The Vascular Society
Outcomes after Elective Repair of Infra-renal Abdominal Aortic Aneurysm A report from The Vascular Society March 2012 Contents Contents 1 Foreword 3 Preface 4 Authors 6 Glossary 7 About this report 8 Executive
More informationCardiology Department. Clinical Governance
Cardiology Department Clinical Governance Background Cardiology department has a high throughput of emergency and elective patients Two acute sites CAH and DHH Cardiac investigation department provides
More informationAustralia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes
Australia and New Zealand Source Registry Edwards Sapien Aortic Valve 30 day Outcomes A/ Professor Darren Walters On behalf of the ANZ Source Investigators Director of Cardiology Brisbane, Australia ANZ
More informationAudit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. East Anglia Local Area Team
Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT East Anglia Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians, academics and managers which
More informationWhen Should We Consider TAVI. (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea
When Should We Consider TAVI Procedure in Korea (Surgeon s Viewpoint)? Pyowon Park Samsung Medical Center Seoul, Korea Aortic Stenosis in Korea Rapidly increasing valve disease in Korea Still low incidence
More informationAntonio Colombo. Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy. Miracor Symposium. Speaker: 15. Parigi: May 16-19, 2017
Parigi: May 16-19, 2017 Miracor Symposium Speaker: 15 Antonio Colombo Centro Cuore Columbus and S. Raffaele Scientific Institute, Milan, Italy Nothing to disclose PiCSO Impulse System Elective high risk
More informationTranscatheter Aortic Valve Implantation (TAVI)
Transcatheter Aortic Valve Implantation (TAVI) QEH Registry A Multidisciplinary Team Approach Michael KY Lee 1, LK Chan 1, KC Chan 1, KT Chan 1, SF Chui 1, HS Ma 1, CY Wong 1, CS Chiang 1, P Li 1, CB Lam
More informationPCI Update Qesaria 2009
PCI Update Qesaria 2009 Amit Segev Interventional Cardiology Chaim Outline Primary PCI Non-ST elevation ACS Multi-vessel disease Hemodynamic assessment of borderline lesions - FFR Stable AP Non-coronary
More informationCase Presentations TAVR: The Good Bad and The Ugly
Case Presentations TAVR: The Good Bad and The Ugly Vincent J. Pompili, MD, FACC, FSCAI Professor of Internal Medicine Director of Interventional Cardiovascular Medicine and Cardiac Catheterization Laboratories
More information2/26/2013. NCDR.13 Case Scenario Presentation Cath PCI Registry. Disclosures. Objectives. Dashboard Implications of Some Major Metrics
NCDR.13 Case Scenario Presentation Cath PCI Registry Dashboard Implications of Some Major Metrics Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Cornelia Anderson
More information1-YEAR OUTCOMES FROM JOHN WEBB, MD
1-YEAR OUTCOMES FROM JOHN WEBB, MD ON BEHALF OF THE SAPIEN 3 INVESTIGATORS UNIVERSITY OF BRITISH COLUMBIA VANCOUVER, CANADA Potential conflicts of interest Speaker's name: John Webb I have the following
More informationVascular Access Audit Report 2012 UK Renal Registry and NHS Kidney Care. Kidney Care. Better Kidney Care for All
Kidney Care Vascular Access Audit Report 2012 UK Renal Registry and NHS Kidney Care Dr Richard Fluck Mr David Pitcher Mrs Retha Steenkamp Better Kidney Care for All Contents Page 1 Foreword... 2 Acknowledgements...
More informationTAVI: Transapical Procedures
Cardiology Update Davos TAVI: Transapical Procedures Volkmar Falk, MD University Hospital Zürich TA-AVI: antegrade, simple, safe The front door approach! Transapical TAVI Technical advantages of TA approach
More informationWales North Cardiac Network
Wales North Cardiac Network David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit
More informationPercutaneous Intervention of Unprotected Left Main Disease
Percutaneous Intervention of Unprotected Left Main Disease Technical feasibility and Clinical outcomes Seung-Jung Park, MD, PhD, FACC Professor of Internal Medicine Asan Medical Center, Seoul, Korea Unprotected
More informationWales North Cardiac Network
David Cunningham Director, Central Cardiac Audit Database Richard Charles Chairman, Network Device Survey Group Morag Cunningham CRM Database Coordinator, Central Cardiac Audit Database Adél de Lange Data
More informationClinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT South West London Cardiac Network
2011 Clinical Audit of Heart Rhythm Devices Pacemaker, ICD and CRT South West London Cardiac Network David Cunningham Senior Strategist, NICOR Morag Cunningham CRM Database Coordinator, NICOR Richard Charles
More informationEvolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands
Evolution In Interventional Cardiology Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands 25 November 2010 Coronary Atherosclerosis Timeline in interventional cardiology Indications for
More informationTranscatheter Aortic Valve Implantation. SSVQ November 23, 2012 Centre Mont-Royal 15:40
Transcatheter Aortic Valve Implantation SSVQ November 23, 2012 Centre Mont-Royal 15:40 Nicolo Piazza MD, PhD, FRCPC, FESC, FACC McGill University Health Center German Heart Center Munich 1 First-in-Human
More informationTHE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON
THE PERCUTANEOUS MANAGEMENT OF VALVULAR HEART DISEASE DR JOHN RAWLINS CONSULTANT INTERVENTIONAL CARDIOLOGIST UNIVERSITY HOSPITAL SOUTHAMPTON INTRODUCTION History of heart valve intervention Current indications
More informationJoint Congress PAFCIC Complex PCI meeting
Joint Congress PAFCIC Complex PCI meeting October 18-20, 2018, Nairobi, KENYA The Program : - Interactive sessions - Practical workshops - Key note lectures - Live transmissions - Poster and oral presentations
More informationVascular access. The KidneyCare Audit
Vascular access The KidneyCare Audit Renal National Service Framework The challenge of vascular access Standard 3 All children, young people and adults with established renal failure are to have timely
More informationNCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry
A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:
More informationST-Elevation Myocardial Infarction & Cardiogenic Shock. - What Should We Do?
ST-Elevation Myocardial Infarction & Cardiogenic Shock - What Should We Do? Advanced Angioplasty 2008 Dan Blackman Leeds General Infirmary Conflicts of interest Advisory Boards Cordis Boston Scientific
More informationTranscatheter Aortic Valve Implantation Present Status and Perspectives
Transcatheter Aortic Valve Implantation Present Status and Perspectives Angioplasty Summit TCTAP 2010 Alain Cribier, MD University of Rouen, France Transcatheter Aortic Valve Implantation has entered the
More informationPercutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives. Bernard Iung Bichat Hospital, Paris
Percutaneous Treatment of Valvular Heart Diseases: Lessons and Perspectives Bernard Iung Bichat Hospital, Paris Euro Heart Survey on Valvular Diseases 3547 Patients with Native Valve Disease n= 1250 1000
More informationDr. Jean-Claude Laborde
Medtronic CoreValve Experience Alternative Access (Subclavian) and Technology Evolution of the Medtronic CoreValve TAVI System Dr. Jean-Claude Laborde Glenfield Hospital, Leicester, U.K. St George Hospital,
More informationPercutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update
Percutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update T. Lefèvre Natural History of Aortic Stenosois 100 Latent period Survival (%) 80 60 40 20 Symptoms Average Age Death 0 40 50
More informationTranscatheter Aortic Valve Implantation (TAVI) Overview for Wales. Dr Richard Anderson University Hospital of Wales, Cardiff, UK
Transcatheter Aortic Valve Implantation (TAVI) Overview for Wales Dr Richard Anderson University Hospital of Wales, Cardiff, UK Aortic stenosis is a disease of old age Age demographics in Wales % Wales
More informationUnprotected LM intervention
Unprotected LM intervention Guideline for COMBAT Seung-Jung Park, MD, PhD Professor of Internal Medicine, Seoul, Korea Current Recommendation for unprotected LMCA Stenosis Class IIb C in ESC guideline
More informationDiagnostic & Therapeutic Cardiac Catheterization Coder 2017
Diagnostic & Therapeutic Cardiac Catheterization Coder 2017 Including peripheral and cardiovascular services and procedures Prepared and Published By: MedLearn Publishing A Division of Panacea Healthcare
More information8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference Dubai: October Acute Coronary Syndromes
8th Emirates Cardiac Society Congress in collaboration with ACC Middle East Conference 2017 OSPEDALE Dubai: 19-21 October 2017 Acute Coronary Syndromes Antonio Colombo Centro Cuore Columbus and S. Raffaele
More informationUpdate on Percutaneous Therapies for Structural Heart Disease. William Thomas MD Director of Structural Heart Program Tucson Medical Center
Update on Percutaneous Therapies for Structural Heart Disease William Thomas MD Director of Structural Heart Program Tucson Medical Center NCVH 2014- Tucson Disclosure of Financial Interest Research: Stock
More informationTAVI at Liverpool Heart & Chest Hospital. National Audit of Cardiac Services in Wales Wrexham 28/11/2012
TAVI at Liverpool Heart & Chest Hospital National Audit of Cardiac Services in Wales Wrexham 28/11/2012 Mr Aung Oo FIRSTTAVI TAVI IMPLANT IN SEPTEMBER 2008 LHCH TAVI Team Cardiologists Rod Stables, Joe
More informationMid-term results from real-world REPARA registry. Felipe Hernandez, on behalf of the REPARA investigators
Mid-term results from real-world REPARA registry Felipe Hernandez, on behalf of the REPARA investigators Potential conflicts of interest Speaker's name: Felipe Hernandez I have the following potential
More informationPUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR
PUMP FAILURE COMPLICATING AMI: ISCHAEMIC VSR Dr Susanna Price MD PhD MRCP ESICM FFICM FESC Consultant Cardiologist & Intensivist Royal Brompton & Harefield NHS Foundation Trust DECLARATIONS Educational
More informationTranscatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee
Transcatheter Aortic Valve Implantation (TAVI) - 5 important lessons learnt from HK experiences Michael KY Lee Queen Elizabeth Hospital, Hong Kong President, HKSTENT APCASH 2013 SJ Park TAVI Summit 2013
More informationEdwards Transcatheter AVR: Have the Outcomes Changed after CE Approval?
Edwards Transcatheter AVR: Have the Outcomes Changed after CE Approval? Update from PARTNER EU and SOURCE Registries T. Lefèvre Disclosure Statement Cardiologist Interventional cardiologist 1 st PABV in
More information14 January Dear Endometriosis Centre Lead
14 January 2017 Dear Endometriosis Centre Lead Thank you for your continued support of the Endometriosis Centres Project. With this letter is the summary of data from all the centres for 2016 as we have
More informationAudit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT. Cumbria, Northumberland, Tyne and Wear Local Area Team
Audit of Cardiac Rhythm Management Devices Pacemaker, ICD and CRT Cumbria, Northumberland, Tyne and Wear Local Area Team 2012 Acknowledgments is a partnership of clinicians, IT experts, statisticians,
More informationRationale for Prophylactic Support During Percutaneous Coronary Intervention
Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories
More informationPrincipal Treatment Centres What do the data say for childhood cancer?
Principal Treatment Centres What do the data say for childhood cancer? Charles Stiller National Registry of Childhood Tumours (NRCT) Childhood Cancer Research Group (CCRG) Children s Cancer and Leukaemia
More informationRichard Grocott Mason
Richard Grocott Mason What to do with a 50 year old man with chest pain? Does the pain sound cardiac? Is this a possible acute coronary syndrome? Does patient have a previous cardiac history? Natural history
More informationWhen Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E
When Aspiration Thrombectomy Does Not Work? A A R O N W O N G N A T I O N A L H E A R T C E N T R E S I N G A P O R E Thrombus in STEMI Over 70% of STEMI patients has angiographic evidence of thrombus
More informationCoronary interventions
Controversial issues in the management of ischemic heart failure Coronary interventions Maciej Lesiak Department of Cardiology, University Hospital in Poznan none DECLARATION OF CONFLICT OF INTEREST CHF
More informationTREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4
1 TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA FDA APPROVES IMPELLA FOR HIGH-RISK PCI 2 Impella is the only hemodynamic support device proven safe and effective in elective
More informationCan Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!
Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,
More informationPatient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization
Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization + K Spargias, MD, PhD THV Director Hygeia Hospital Disclosures - Proctor
More informationRoyal Marden Education & Conference Centre, London Total 4 (2 per day) 3D Echo meeting Nottingham 3
2nd Annual Intensive Exam-Focused Congenital Echocardiography Course (2-3 October 2014) The Draycott Conference Centre, London Total 4 (2 per day) 3rd Annual Intensive Exam Orientated Congenital Echocardiography
More informationLate Breaking Clinical Trials: The Consistent CTO study
Late Breaking Clinical Trials: The Consistent CTO study CONventional antegrade vs Sub-Intimal Synergy stenting in Chronic Total Occlusions Dr Simon Walsh on behalf of the Consistent CTO Investigators Introduction
More informationWho is the high risk patient?
Who is the high risk patient? High risk of periprocedural death or other major complications (hemodynamic compromise, MI, stroke, dialysis) Contributors of Risk Lesion/Procedure Governed by 1. Patient
More informationPeripheral and Cardiology Coder 2018
Peripheral and Cardiology Coder 2018 Cardiovascular Services and Procedures Prepared and Published By: MedLearn Publishing A Division of MedLearn Media, Inc. 445 Minnesota Street, Suite 514 St. Paul, MN
More informationTransplant Activity in the UK
Transplant Activity in the UK 2006-2007 This document has been produced by the Statistics and Audit Directorate. UK Transplant August 2007 Cover pictures: Members of Glamorgan County cricket team help
More informationResearch Involving RaDaR: Nephrotic Syndrome - NephroS/ NURTuRE Studies. Liz Colby Project Manager, University of Bristol
Research Involving RaDaR: Nephrotic Syndrome - NephroS/ NURTuRE Studies Liz Colby Project Manager, University of Bristol What is Nephrotic Syndrome? Breakdown of the glomerular filtration barrier Massive
More informationManagement of Non-protected Left-Main Bifurcation without Drug Eluting Stent. Masahiko Ochiai MD, FACC, FESC, FSCAI
Management of Non-protected Left-Main Bifurcation without Drug Eluting Stent Masahiko Ochiai MD, FACC, FESC, FSCAI Division of Cardiology and Cardiovascular Surgery Showa University Northern Yokohama Hospital
More informationHow to manage device embolization?
How to manage device embolization? Swiss Fellow Course Interventional Cardiology Amir-Ali Fassa Hôpital de La Tour Meyrin, Geneva Coronary interventions: Definitions Stent loss: stent dislodgment from
More informationIncorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI)
Incorporating the intermediate risk in Transcatheter Aortic Valve Implantation (TAVI) Larry S. Dean, MD, MSCAI Past President SCAI Professor of Medicine and Surgery University of Washington School of Medicine
More information